Xtant Medical Holdings (XTNT) Cash & Equivalents (2010 - 2025)

Xtant Medical Holdings (XTNT) has 16 years of Cash & Equivalents data on file, last reported at $17.1 million in Q4 2025.

• On a quarterly basis, Cash & Equivalents rose 175.09% year-over-year to $17.1 million in Q4 2025; TTM through Dec 2025 was $17.1 million, a 175.09% increase from a year earlier, with the FY2025 full-year figure at $17.1 million, up 175.09% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $17.1 million, up from $10.4 million in the prior quarter.
• Over the last five years, Cash & Equivalents for XTNT reached as high as $20.3 million in Q2 2021 and fell as low as $4.1 million in Q2 2023.
• Historically, Cash & Equivalents has averaged $11.6 million across 5 years, with a median of $9.5 million in 2023.
• Across the five-year window, Cash & Equivalents soared 679.28% in 2021 and sank 74.91% in 2023, its largest moves.
• Year by year, Cash & Equivalents stood at $18.2 million in 2021, then gained by 11.26% to $20.3 million in 2022, then tumbled by 71.84% to $5.7 million in 2023, then gained by 8.47% to $6.2 million in 2024, then surged by 175.09% to $17.1 million in 2025.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $17.1 million in Q4 2025, $10.4 million in Q3 2025, and $6.9 million in Q2 2025.